Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Inherited Neurologic Disorders Traced to Chromosome 15

By Biotechdaily staff writers
Posted on 10 Oct 2003
Researchers have identified mutations in four genes on chromosome 15 that give rise to several related inherited neurologic syndromes. More...
The disorders include Prader-Willi syndrome, Angelman syndrome, and hereditary spastic paraplegia (HSP).

HSP is a group of clinically and genetically diverse disorders that share the primary feature of progressive, generally severe, lower extremity spasticity. HSP is classified as "uncomplicated” (symptoms confined to lower extremity weakness, bladder disturbance, and to a lesser extent impaired position sense in the legs) or "complicated,” when additional neurologic deficits are present. Prader-Willi occurs when the defective chromosome is inherited from the father, and it features mild cognitive impairment and morbid obesity. Angelman is inherited from the mother and is characterized by seizures, movement disorders, and severe mental retardation. Prader-Willi and Angelman syndromes occur in one in every 12,000 to 15,000 births.

Investigators at the University of Pennsylvania School of Medicine (Philadelphia, USA; www.upenn.edu) reported in two papers in the October 2003 issue of the American Journal of Human Genetics that breakpoint regions on chromosome 15 contribute to chromosome rearrangements in evolution but in individuals may cause Prader-Willi and Angelman syndromes. They identified four genes, NIPA1, NIPA2, CYFIPI, and GCP5, in the unstable area of chromosome 15. A mutation in NIPA1 was found in families where members suffered from hereditary spastic paraplegia.

"Genes located in this part of chromosome 15 sit among a lot of genetic flotsam and duplicated regions we refer to as breakpoint regions. In the grand scheme of things, this is an evolutionary plus for humans, as these regions are prone to genetic recombination, duplication, and other forms of gene shuffling that can add diversity to the human genome in the process of passing down chromosomes,” explained senior author Dr. Robert D. Nicholls, professor of psychiatry and genetics at the University of Pennsylvania. "In individuals, however, it can cause disease.”

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.